| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |